The latest market intelligence report, titled ‘Global radiotherapy Market’, is intended to provide the target audience with the necessary information about the global radiotherapy industry. The report comprises a detailed analysis of the vital elements of the radiotherapy market, including key drivers, constraints, opportunities, limitations, threats, and micro- and macro-economic factors. The report carefully investigates the present market scenario and the fundamental growth prospects. The report entails an organized database of the radiotherapy market dynamics that helps market analysts estimate the global market growth rate over the projected timeline.
Our experienced market research team has provided updated information on the ongoing COVID-19 pandemic and its adverse economic impact in the latter segment of the report. The coronavirus outbreak has led to drastic changes in the current radiotherapy business landscape, limiting the growth opportunities for various manufacturers and buyers for the next few years. Besides making speculations about the market’s post-COVID-19 scenario, the report discusses its existing situation. The report eventually offers conclusive data related to the radiotherapy market growth assessed on both regional and global levels.
Get a Free sample of the report : https://www.emergenresearch.com/request-sample/49
Increasing technological advances in the radiotherapy is one of the factors snowballing, the market growth. For instance, Stereotactic body radiation therapy (SBRT) which differentiate between healthy cells and cancer cells and provide optimum efficacy
Continuous rising prevalence of cancer resulting, a raised demand of radiotherapy eventually promoted the market growth. According to the American Cancer Society, approximately 1,806,590 new cancer cases and 606,520 cancer deaths in the U.S. are estimated in the year 2020.
Some Key Highlights from the Report
Rising technological advances and increasing prevalence of cancer many field players are engaged in investing new product development. For instance, in June 2020, a subsidiary company of the ALCEN group “PMB” launched FLASHKNiFE, the FLASH radiotherapy system used for clinical trials
Continue increasing demand for technological advances in the market promoted several market players to develop advanced version of their product offerings. For instance, in January 2020, Elekta signed an agreement with the Institute Jules Bordet, Brussels for Elekta Unity MR-linac system, Versa H.D. linear accelerators (linacs), and to upgrade Elekta Infinity linacs. The total contract was valued at approximately USD 24.2 million. This was beneficial to provide Bordet institute advanced radiotherapy solutions.
With the rise in the prevalence of cancer, most of the hospitals are adopting efficient products offering optimum treatment. For instance, in January 2020, Provision Healthcare launched third proton therapy center installation in Southwest Orange County, Florida. The center is expected to treat approximately 700 patients per year and will be equipped with next-generation oncology information system RayCare and treatment planning system RayStation from RaySearchHospitals and clinics are the major end-users of the market.
Various technologies like AI, personalization or miniaturization have contributed significant share of growth, to capture the client need field operators have initiated emerging such technologies. For instance, in September 2019, Varian (U.S) software developer in partnership with Oncora (U.S.) a digital health company launched Ethos artificial intelligence radiotherapy device
Radiotherapy is widely used as a prostate cancer treatment. Increasing incidence rate of cancer globally and higher rate of efficiency are major driving factor enhancing market growth
North America is anticipated to witness several growth opportunities leading to the increase in the level of awareness among consumers owing to the availability of a large number of research institutes, hospitals and other healthcare facilities, and also rise in the prevalence of cancer, which will significantly influence the growth of the industry.
Key participants include Varian Medical Systems, Inc. (U.S.), Elekta (Sweden), Accuray Incorporated (U.S.), Ion Beam Applications S.A. (Belgium), Panacea Medical Technologies Pvt. Ltd. (India), ViewRay, Inc. (U.S.), IsoRay Medical, Inc. (U.S.), Provision Healthcare (U.S.), Hitachi Ltd. (Japan), Mevion Medical Systems, Inc. (U.S.) and Reflexion Medical (U.S.) among others.
Request customization of the report: https://www.emergenresearch.com/request-for-customization/49
Segmental Analysis
The global radiotherapy market is broadly segmented on the basis of different product types, application range, end-use industries, key regions, and an intensely competitive landscape. This section of the report is solely targeted at readers looking to select the most appropriate and lucrative segments of the radiotherapy sector in a strategic manner. The segmental analysis also helps companies interested in this sector make optimal business decisions and achieve their desired goals.
Emergen Research have segmented the global Radiotherapy Market on the basis of products, types, applications, end-users, and region:
Products Outlook (Revenue in Million USD; 2017–2027)
- External Beam Radiotherapy Product
- Linear Accelerators (LINAC)
- Conventional LINAC
- Stereotactic Advanced Electron/Cobalt-60 LINAC
- CyberKnife
- Gamma Knife
- TomoTherapy
- Particle Therapy Systems
- Cyclotrons
- Synchrotrons
- Synchrocyclotrons
- Conventional Cobalt-60 Teletherapy Units
- Internal Beam Radiotherapy/Brachytherapy Products
- Seeds
- Applicators
- Afterloaders
- Electronic Brachytherapy Products
- Systemic Radiotherapy
- Iobenguane-131
- Samarium-153
- Rhenium-186
- Yttrium-90
- Radium-223
- Phosphorous-32
- Radio-Labelled Antibodies
- Linear Accelerators (LINAC)
Types Outlook (Revenue in Million USD; 2017–2027)
- External Beam Radiotherapy
- Image-guided Radiotherapy (IGRT)
- Intensity-modulated Radiotherapy (IMRT)
- TomoTherapy
- Volumetric Modulated Arc Therapy (VMAT)
- Stereotactic Therapy
- 3D Conformal Radiotherapy (3D-CRT)
- Particle Beam Therapy (Heavy-ion and Proton Therapy)
- Internal Beam Radiotherapy/Brachytherapy
- Low-dose-rate (LDR) Brachytherapy
- High-dose-rate (HDR) Brachytherapy
- Pulsed-dose-rate (PDR) Brachytherapy
- Systemic Radiotherapy
- Intravenous Radiotherapy
- Oral Radiotherapy
- Instillation Radiotherapy
Applications Outlook (Revenue in Million USD; 2017–2027)
- Prostate Cancer
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Spine Cancer
- Brain Cancer
- Pediatric Cancer
- Gynecological Cancer
- Cervical Cancer
- Penile Cancer
- Head and Neck Cancer
End Use Outlook (Revenue in Million USD; 2017–2027)
- Hospitals
- Independent Radiotherapy Centers
Key Points of radiotherapy Market:
Extensive coverage of the analysis of the radiotherapy market
Key insights into the regional spread of the industry in key geographies
Radical insights into the vital market trends; both current and emerging trends, and factors influencing the growth of the market
Comprehensive coverage of the impact of the COVID-19 pandemic on the overall growth of the radiotherapy market
Complete data about the key manufacturers and vendors in the radiotherapy market
Read More: https://www.emergenresearch.com/industry-report/radiotherapy-market
Related reports:
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Facebook | LinkdIn | Twitter | Blogs
